Evelo Biosciences, Inc. (EVLO)
Develops oral medicines using beneficial gut bacteria to treat immune system disorders.
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-80.0%
The outlook
EVLO is trading at its 52-week low with a StockGlow score of 3/100, reflecting weak sentiment. The stock sits substantially below both its 50- and 200-day moving averages, indicating a downtrend. Analyst coverage appears thin or unavailable for this micro-cap security.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$1,898
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—